Effect of Acetyl-L-carnitine in Migraine

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

September 30, 2014

Conditions
Migraine
Interventions
DRUG

Acetyl-L-carnitine

Week 1: 500 mg x 3, Week 2-12: 500 mg x 6

Trial Locations (1)

7489

Norwegian National Headache Centre, Trondheim

All Listed Sponsors
lead

Norwegian University of Science and Technology

OTHER

NCT01695317 - Effect of Acetyl-L-carnitine in Migraine | Biotech Hunter | Biotech Hunter